Yehia Hashad

2.2k total citations · 1 hit paper
17 papers, 1.7k citations indexed

About

Yehia Hashad is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Yehia Hashad has authored 17 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Ophthalmology, 11 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Molecular Biology. Recurrent topics in Yehia Hashad's work include Retinal Diseases and Treatments (13 papers), Retinal Imaging and Analysis (10 papers) and Retinal and Optic Conditions (6 papers). Yehia Hashad is often cited by papers focused on Retinal Diseases and Treatments (13 papers), Retinal Imaging and Analysis (10 papers) and Retinal and Optic Conditions (6 papers). Yehia Hashad collaborates with scholars based in United States, Italy and Germany. Yehia Hashad's co-authors include Scott M. Whitcup, Xiaoyan Li, Harry Cui, Raj K. Maturi, Francesco Bandello, Young Hee Yoon, Rubens Belfort, Albert J. Augustin, David S. Boyer and Lee-Jen Chen and has published in prestigious journals such as Ophthalmology, Investigative Ophthalmology & Visual Science and British Journal of Ophthalmology.

In The Last Decade

Yehia Hashad

16 papers receiving 1.6k citations

Hit Papers

Three-Year, Randomized, S... 2014 2026 2018 2022 2014 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yehia Hashad United States 11 1.6k 1.1k 138 40 24 17 1.7k
Allison R. Ayala United States 13 1.5k 0.9× 1.4k 1.2× 223 1.6× 79 2.0× 12 0.5× 24 1.7k
Prema Abraham United States 12 1.8k 1.1× 1.5k 1.3× 210 1.5× 16 0.4× 18 0.8× 22 1.8k
Eduardo Dib Brazil 15 486 0.3× 434 0.4× 168 1.2× 24 0.6× 80 3.3× 25 602
Ana Rita Santos Portugal 18 753 0.5× 664 0.6× 81 0.6× 5 0.1× 13 0.5× 58 871
Young Kwang Chu South Korea 10 388 0.2× 273 0.2× 106 0.8× 18 0.5× 42 1.8× 18 460
Nicola Delle Noci Italy 16 578 0.4× 466 0.4× 157 1.1× 130 3.3× 41 1.7× 34 780
I‐Van Ho Australia 14 773 0.5× 523 0.5× 136 1.0× 11 0.3× 73 3.0× 27 907
Nour Maya N. Haddad United States 8 405 0.3× 331 0.3× 80 0.6× 21 0.5× 17 0.7× 14 496
Asheesh Tewari United States 11 686 0.4× 509 0.4× 164 1.2× 11 0.3× 93 3.9× 26 785
Marc Figueras‐Roca Spain 14 294 0.2× 201 0.2× 65 0.5× 24 0.6× 18 0.8× 44 400

Countries citing papers authored by Yehia Hashad

Since Specialization
Citations

This map shows the geographic impact of Yehia Hashad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yehia Hashad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yehia Hashad more than expected).

Fields of papers citing papers by Yehia Hashad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yehia Hashad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yehia Hashad. The network helps show where Yehia Hashad may publish in the future.

Co-authorship network of co-authors of Yehia Hashad

This figure shows the co-authorship network connecting the top 25 collaborators of Yehia Hashad. A scholar is included among the top collaborators of Yehia Hashad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yehia Hashad. Yehia Hashad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Kunimoto, Derek, Young Hee Yoon, Charles C. Wykoff, et al.. (2020). Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration. Ophthalmology. 127(10). 1331–1344. 69 indexed citations
3.
Khurana, Rahul N., Derek Kunimoto, Young Hee Yoon, et al.. (2020). Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration. Ophthalmology. 128(7). 1027–1038. 31 indexed citations
4.
Yoon, Young Hee, David S. Boyer, Raj K. Maturi, et al.. (2019). Natural history of diabetic macular edema and factors predicting outcomes in sham-treated patients (MEAD study). Graefe s Archive for Clinical and Experimental Ophthalmology. 257(12). 2639–2653. 10 indexed citations
5.
Tufail, Adnan, Susan Lightman, Ahmed Kamal, et al.. (2018). Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis. Clinical ophthalmology. Volume 12. 2519–2534. 22 indexed citations
6.
Li, Xiaoxin, Ningli Wang, Xiaoling Liang, et al.. (2017). Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study. Graefe s Archive for Clinical and Experimental Ophthalmology. 256(1). 59–69. 40 indexed citations
7.
Callanan, David, Anat Loewenstein, Sunil Patel, et al.. (2016). A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema. Graefe s Archive for Clinical and Experimental Ophthalmology. 255(3). 463–473. 75 indexed citations
8.
Maturi, Raj K., Ayala Pollack, Harvey S. Uy, et al.. (2016). INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY. Retina. 36(6). 1143–1152. 94 indexed citations
9.
Danis, Ronald P., Srinivas R. Sadda, Xiaoyan Li, et al.. (2015). Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials. British Journal of Ophthalmology. 100(6). 796–801. 26 indexed citations
10.
Augustin, Albert J., Baruch D. Kuppermann, Paolo Lanzetta, et al.. (2015). Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. BMC Ophthalmology. 15(1). 150–150. 53 indexed citations
11.
Genead, Mohamed A., et al.. (2014). Evaluation of the Test-Retest Reliability of the Electronic-ETDRS Visual Acuity Tester. Investigative Ophthalmology & Visual Science. 55(13). 163–163. 1 indexed citations
12.
Boyer, David S., Young Hee Yoon, Rubens Belfort, et al.. (2014). Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema. Ophthalmology. 121(10). 1904–1914. 794 indexed citations breakdown →
13.
Yoon, Young Hee, David S. Boyer, Rubens Belfort, et al.. (2014). Long-term Efficacy and Safety of Dexamethasone Intravitreal Implant in Phakic and Pseudophakic Eyes with Diabetic Macular Edema. 55(13). 1779–1779. 2 indexed citations
14.
Koh, Adrian, Won Ki Lee, Lee-Jen Chen, et al.. (2012). EVEREST STUDY. Retina. 32(8). 1453–1464. 456 indexed citations
16.
Wolf, Sebastián, Frank G. Holz, Korobelnik Jf, et al.. (2011). Outcomes following three-line vision loss during treatment of neovascular age-related macular degeneration: subgroup analyses from MARINA and ANCHOR. British Journal of Ophthalmology. 95(12). 1713–1718. 12 indexed citations
17.
Lanzetta, Paolo, Gabriela Burian, Andreas Weichselberger, & Yehia Hashad. (2010). Safety Profiles of Diabetic versus Non-Diabetic AMD Patients in Randomized Controlled Clinical Studies With Ranibizumab. Investigative Ophthalmology & Visual Science. 51(13). 91–91. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026